ACE and cardiac arrhythmia: Both Angiotensin 1 Receptor (AT1R) antagonists as well as Angiotensin Converting Enzyme (ACE) inhibitors have improved cardiac remodeling of the ECM and hypertrophy, together with reduction of arrhythmias, in pre-clinical testing (144–146).